FFANX | HBLRX | FFANX / HBLRX | |
Total Expense Ratio | 0.51 | 1.28 | 40% |
Annual Report Gross Expense Ratio | 0.51 | 1.28 | 40% |
Fund Existence | 18 years | 15 years | - |
Gain YTD | 11.342 | 8.426 | 135% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | 500 | N/A | - |
Net Assets | 2.41B | 11.8B | 20% |
Annual Yield % from dividends | 2.51 | 2.89 | 87% |
Returns for 1 year | 9.71 | 1.78 | 546% |
Returns for 3 years | 33.65 | 22.80 | 148% |
Returns for 5 years | 25.21 | 13.81 | 183% |
Returns for 10 years | 58.74 | 40.84 | 144% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPCX | 13.58 | 0.13 | +0.97% |
Saratoga Health & Biotechnology C | |||
JEPRX | 14.12 | 0.08 | +0.57% |
JPMorgan Equity Premium Income R6 | |||
RPMFX | 16.48 | 0.09 | +0.55% |
Reinhart Genesis PMV Advisor | |||
GMZPX | 38.72 | 0.14 | +0.36% |
Goldman Sachs Large Cap Gr Insghts P | |||
GCINX | 15.89 | -0.01 | -0.06% |
Green Century MSCI Intl Indx Indvl Inv |